Survival Benefit of Implantable Cardioverter-Defibrillators in Left Ventricular Assist Device–Supported Heart Failure Patients
- 29 February 2012
- journal article
- Published by Elsevier BV in Journal of Cardiac Failure
- Vol. 18 (2), 140-145
- https://doi.org/10.1016/j.cardfail.2011.10.020
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Ion-channel mRNA-expression profiling: Insights into cardiac remodeling and arrhythmic substratesJournal of Molecular and Cellular Cardiology, 2010
- Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist DeviceThe New England Journal of Medicine, 2009
- Incidence and Patterns of Adverse Event Onset During the First 60 Days After Ventricular Assist Device ImplantationThe Annals of Thoracic Surgery, 2009
- Incidence of Ventricular Arrhythmias in Patients on Long-term Support With a Continuous-flow Assist Device (HeartMate II)The Journal of Heart and Lung Transplantation, 2009
- Left Ventricular Mechanical Assist Devices and Cardiac Device Interactions: An Observational Case SeriesPacing and Clinical Electrophysiology, 2009
- Ventricular Arrhythmias after Left Ventricular Assist Device ImplantationPacing and Clinical Electrophysiology, 2008
- Obesity, Insulin Resistance, and the Metabolic SyndromeCirculation, 2005
- Effects of Left Ventricular Assist Device Therapy on Ventricular ArrhythmiasJournal of the American College of Cardiology, 2005
- Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection FractionThe New England Journal of Medicine, 2002
- Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart FailureThe New England Journal of Medicine, 2001